Deere Reports Tuesday. The FY2027 Guide Is What Counts.

Deere & Company reports fiscal fourth-quarter 2026 results before the open on November 25, and for once the quarterly numbers are almost beside the point. Consensus sits at roughly $4.07 EPS on $10.35 billion in revenue, a 6% improvement against a quarter a year ago that produced $9.81 billion and $3.83 per share. Meeting that bar requires nothing heroic. What investors actually need to hear is what fiscal 2027 looks like without the crutches.

Those crutches are specific and sizable. Deere recorded $382 million in tariff recoveries through the first nine months of fiscal 2026, including $110 million in Q3, tied to refunds after the Supreme Court invalidated certain IEEPA tariffs. The company has also said it assumes no further recoveries for the remainder of the fiscal year ending in November. That means investors should treat these credits as nonrecurring tailwinds that are unlikely to repeat in fiscal 2027, creating an immediate profit and margin headwind before accounting for any new tariff expenses. The company’s current full-year 2026 net income guidance of $4.75 billion to $5.00 billion was raised at the Q3 call on August 20, up from the prior range of $4.50 billion to $5.00 billion.

Where the Cycle Stands

CEO John May has repeatedly called 2026 the bottom of the agricultural equipment cycle, and Q3 results arrived with $1.379 billion in net income and $5.10 per share, up about 7% year over year. The stock fell anyway, as investors want evidence of the recovery, not repetition of the call.

The evidence is uneven. Rising U.S. government and private infrastructure spending, alongside the AI-fueled buildout of data centers, has lifted construction equipment demand, with Deere’s construction and forestry segment posting 18% quarterly net sales growth. Small Agriculture and Turf has also been a bright spot. Small Ag and Turf sales are expected to rise about 15% for the full fiscal year. The core business, Production and Precision Agriculture, the large tractors and combine harvesters that define Deere’s brand, is a different story: those sales are expected to fall about 10% for the full year.

North American inventories of high-horsepower tractors and combines are down more than 50% from their mid-2024 peak, with used inventories also declining. That is the structural foundation of the recovery argument. Farmers who deferred purchases for three years eventually need new machines.

What the Market Has Already Decided

Here is the tension long-term investors need to sit with. Shares have risen around 39% in 2026, so investors are no longer buying Deere simply as a depressed cyclical stock. They are paying for an expected recovery in 2027. Analyst consensus has fiscal 2027 EPS rising about 29% year over year to roughly $23.40.

Management itself has described fiscal 2026 as the bottom of the farm equipment cycle, though it expects a measured recovery rather than a sharp rebound in 2027. That qualifier matters. A measured recovery while lapping tariff-refund benefits is a very different earnings trajectory than a sharp one.

The Wealth-Building Case

Deere at a cycle trough is exactly the kind of durable business long-term investors are supposed to own when the news is bad. Farm equipment demand is deeply cyclical, tracking crop prices, farmer incomes, and used-inventory levels, and Deere is the bellwether the market uses to express a view on all of it. No competitor comes close in North American row-crop agriculture, and its technology platform, with precision agriculture software renewal rates above 90%, creates switching costs that AGCO and CNH simply cannot replicate at scale.

The risk is valuation. Shares closed at $609.25 on November 20, offering a dividend yield of about 1.04%. At those levels, the stock is not pricing in distress. It is pricing in a recovery. Tariffs and weak farm equipment demand remain near-term headwinds even after the year’s strong rally.

Tuesday’s number to watch is not the EPS figure. It is how management frames fiscal 2027 volume in Production and Precision Agriculture, the shape of the early order program, and whether the guidance midpoint absorbs the loss of tariff-refund benefits without flinching. That is the first clean look at where this cycle truly bottoms, and how much of the eventual recovery investors have already bought.

Daily Wealth Takeaway: Great businesses bought at cycle troughs can compound wealth for years. The discipline is verifying that the stock price still reflects the trough, not the peak of the recovery everyone expects to follow.